SurModics (SRDX) Gets a Buy From Lake Street
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)
Needham Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Analyst Ratings
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Raised to Buy From Hold by Lake Street
Surmodics Price Target Maintained With a $43.00/Share by Lake Street
Surmodics Analyst Ratings
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Lake Street Upgrades SurModics(SRDX.US) to Buy Rating, Maintains Target Price $43
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mind Medicine (MNMD), SurModics (SRDX) and Enhabit, Inc (EHAB)
Lake Street Maintains SurModics(SRDX.US) With Hold Rating, Maintains Target Price $43
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Analyst Ratings
Needham Maintains SurModics(SRDX.US) With Hold Rating
SurModics Hold Rating: Balancing Revenue Slowdown and Acquisition Uncertainty
Lake Street Maintains SurModics(SRDX.US) With Hold Rating, Maintains Target Price $43
Lake Street Maintains SurModics(SRDX.US) With Hold Rating, Maintains Target Price $43